A B S T R A C T Lymphocytes were purified from peripheral blood of normal donors 
INTRODUCTION
The alterations in cyclic AMP metabolism that accompany human lymphocyte activation have been well characterized (1, 2) , although the role of these changes remains to be clarified. Abnormalities in cyclic AMP metabolism have been found in lymphocytes from patients with chronic lymphocytic leukemia (CLL)l (3-7). We report here detailed characterizations of adenylate cyclase activity in human thymus-derived (T) and bone marrow-derived (B) lymphocyte subpopulations. These data permit more appropriate comparisons to be made between adenylate cyclase activities in malignant and normal human lymphocytes.
METHODS
Sources of lymphocytes. 21 healthy donors of normal lymphocytes varied in age from 16 to 82 yr old and included 8 females and 13 males. 19 patients with CLL were studied, 14 males and 5 females. The age range was 45-83 yr, with a median of 68 yr. The duration of disease was 1-10 yr, with a median of 3 yr. Peripheral leukocyte counts varied from 10,000 to 164,000/mm3. Eight patients were untreated, four with counts greater than 30,000/mm3 and four with counts below this level. Seven patients had been treated previously with chlorambucil and(or) prednisone (Lederle Laboratories, Div. of American Cyanamid Co., Pearl River, N. Y.), and two of these had received localized radiotherapy to bulky nodal areas. Four patients were currently under treatment with prednisone or chlorambucil.
Purification of lymphocytes. Lymphocytes were purified from freshly drawn defibrinated blood with previously reported procedures (8) . Briefly, the preparative steps involved sedimentation in 1% dextran (Pharmacia Fine Chemicals Inc., Piscataway, N. J.) to remove the bulk of erythrocytes, followed by centrifugational banding upon an aqueous solution of Ficoll (Pharmacia Fine Chemicals Inc.) and Hypaque (Winthrop Laboratories, New York) at 22°C. In some cases, noted specifically in the text, additional purification steps were performed. A fraction enriched for B cells was obtained by collecting cells at the interface, after formation of E rosettes with sheep erythrocytes and recentrifugation at 4°C on Ficoll-Hypaque (9, 10) . Purification of a T-cell enriched population was accomplished by incubating FicollHypaque leukocytes on a nylon wool column at 37°C for 45 min, followed by gentle elution with medium prewarmed to 37°C (11) , or by collecting the pelleted E-rosetted lymphocytes and removing erythrocytes. Lymphocytes purified by these various procedures were suspended in Eagle's minimal essential medium (Flow Laboratories, Inc., Rockville, Md.) containing 10% autologous serum, 2 mM glutamine, 100 U/ml penicillin, and 100 ,ug/ml streptomycin. After 60 min incubation at 37°C in 95% air per 5% CO2, adenylate cyclase activities and cyclic AMP levels were assayed.
Identification of lymphocyte subpopulations. T lymphocytes were identified by the E-rosette technique. Sheep erythrocytes (SRBC, Colorado Serum Co., Denver, Colo.), 2-wk old and stored in modified Alsever's solution were washed three times in veronal buffer containing 0.1% pork skin gelatin. A modification of the method of Hepburn and Ritts (12) was used: 1.25 x 106 washed, human lymphocytes in glass round-bottom tubes were suspended in 10 ul of a 1:20 dilution of washed SRBC in fetal calf serum (Flow Laboratories, Inc.). An additional drop of serum was then added and mixed by agitation, and the cells were incubated at 37°C in a water bath for 15 min, resuspended by twirling, centrifuged at 400g for 5 min, and incubated at 4°C for 18 h. The tubes were then gently rotated until macroscopic clumps were no longer visible. The suspension was taken up in a Pasteur pipet and placed dropwise on vertical microscope slides. B lymphocytes were identified by two techniques, detection of surface membrane immunoglobulin (smlg) with fluorescent rabbit anti-human immunoglobulin and the erythrocyte antibody complement (EAC)-rosette technique. The FicollHypaque-purified lymphocytes from patients with CLL were in all cases predominantly B cells, with a mean of 16% T cells and <1% monocytes. Precise quantification of CLL lymphocytes by fluorescent staining for smlg was hampered by the weakness of surface fluorescence, presumably a result of the reduced numbers of smlg molecules in these cells (13) . Therefore, the EAC-rosette technique was also used, and it gave comparable results.
To prepare an antibody against smlg, immunoglobulin (Ig)G was purified from pooled, human sera by ammonium sulphate precipitation and separation on a DEAE-cellulose column (14) . Antiserum was raised against this human IgG in New Zealand white rabbits, and the IgG in the rabbit antiserum was purified in a similar fashion. Immunoelectrophoresis demonstrated that the rabbit IgG reacted with the human IgG, as well as with IgA and IgM (because of activity against kappa and lambda chains). After conjugation with fluorescein isothiocyanate (Sigma Chemical Co., St. Louis, Mo.), the final concentration of the reagent was adjusted with buffered saline, which contained 1% bovine serum albumin (BSA, Sigma Chemical Co.), to be four times the minimum concentration necessary to label the maximum percentage of normal lymphocytes (15) . The lymphocytes were assayed for smlg as follows: 5 x 105 labeled lymphocytes were placed in polypropylene 1.5-ml microtest tubes (Brinkman Instruments, Inc., Westbury, N. Y.), washed four times with buffered saline, and suspended in 50 gl of the conjugated antibody for 30 min at 0°C. After this incubation, the cells were washed four more times and collected on microscope slides with the cytocentrifuge. After drying, the slides were fixed in methanol and counterstained with acridine orange (0.7 ,ug/ml in 0.1 M Tris-HCl, pH 8.0). Fluorescence microscopy was carried out with an American Optical fluorescence microscope (American Optical Corp., Scientific Instruments Div., Buffalo, N. Y.) equipped with epi-illumination. At least 500 cells were examined.
For the EAC-rosette assay, SRBC were suspended at 5 x 108 cells/ml, incubated at 370C for 30 min with a nonagglutinating titer of rabbit anti-SRBC IgM, washed twice, incubated at 37°C for 30 min with a nonhemolytic titer of human serum as a source of complement (stored at -70°C), washed twice, and adjusted to 108 cells/ml in veronal buffer (16) . 100 pl of this SRBC suspension was mixed with 105 washed lymphocytes in 100 ,ul veronal buffer, centrifuged at 400 g for 5 min, and incubated in a 37°C water bath for 30 min. After this, the supernate was removed and replaced with two drops of veronal buffer with 5% BSA at 370C. The cells were resuspended, and slides were made in the same manner as above. The specimens were concurrently stained for nonspecific esterase (17) to enable the elimination of monocyte EAC rosettes from the scoring.
Adenylate cyclase. The adenylate cyclase assay was modified from the method of Krishna et al. (18) . 3-5 x 106 lymphocytes were placed in polypropylene 1.5-ml microtesttubes and were pelleted by centrifugation at 400 g for 1 min, washed once in 4°C saline, and resuspended in 50 ul of a hypotonic buffer which contained 2 mM Tris-HCl, pH 7.5, 1 mM MgSO4, 0.2% sucrose, and 1 mM dithiothreitol, at 40C. After a 10-min incubation at 4°C, the cell suspension was rapidly frozen in liquid nitrogen and immediately thawed. An additional 50 ,ul of incubation medium was added to give a final concentration of 25 mM Tris-HCl, pH 7.8, 1 mM cyclic AMP, 1.6 mM ATP, 4 mM MgC12, 0.16% BSA, 0.5 mg/ml creatine phosphokinase, 3 mg/ml creatine phosphate, and 1-2 x 106 cpm [a-32P]ATP. Additional concentrated solutions of chemicals and hormones were added in 2-to 4-,ul amounts to yield the stated final concentrations: NaF in saline, 10 mM; L-isoproterenol in 1 mM ascorbic acid, 10 ,uM; D,L-propranolol in 1 mM ascorbic acid, 10 ELM; 5'-guanylyl imidodiphosphate (Gpp[NH]p) in saline, 0.1 mM; and prostaglandin El in ethanol, 10 ,zM. Ethanol and ascorbate controls gave no difference in enzyme activity. After incubation for 20 min at 300C, the reaction was stopped by addition of 100 ,ul of 40 mM EDTA in 30 mM Tris-HCl, pH 7.5. The material was then applied to a 2.5-g neutral alumina column in a Pasteur pipet and eluted with 3 ml 40 mM Tris-HCl, pH 7.5 (19, 20) . The eluate was mixed with 8.5 ml of Bray's scintillation fluid and counted in a Beckman liquid scintillation spectrometer (Beckman Instruments, Inc., Spinco Div., Palo Alto, Calif.). Duplicate assays agreed to within 5.5±1.6%.
The [a-32P]ATP (10-30 Ci/mM, New England Nuclear, Boston, Mass.) was purchased monthly and checked for purity by ascending thin-layer chromatography on Brinkman polygram CEL 300 PEI paper (Brinkman Instuments, Inc.) in a solution of 0.8 M LiCl. More than 96% of the counts were in ATP. This labeled ATP was also tested in a blank reaction mixture to which the EDTA solution was added before the lymphocyte lysate. If >400 cpm were recovered as cyclic AMP in this blank, the [a-32P]ATP was discarded (two occasions), and a fresh batch was obtained. The counts per minute levels observed in assays of base-line enzyme activity were >900.
A variety of methods were tested for optimal lysis of lymphocytes, including treatment with the detergent Triton X-100 (Rohm and Haas Co., Philadelphia, Pa.) (0.1%), sonication at a number of energy levels with' a Bronson sonifier (E. B. Bronson & Co., Inc., Blue Island, Ill.), homogenization in a Potter-Elvehjem tissue grinder for varying numbers of strokes and time intervals, the cavitation in a Parr cell-disruption bomb (Parr Instrument Co., Moline, Ill.). In addition, one to three cycles of freeze-thawing in liquid nitrogen were evaluated. The method of hypotonic swelling followed by a single freeze-thaw step was found to yield optimal and consistent enzyme activity levels.
The composition of the reaction mixture was also standardized. The concentrations of both creatine phosphate and creatine phosphokinase were optimized. We established that addition of unlabeled cyclic AMP as a carrier prevented catabolism of labeled cyclic AMP. Addition of 4 mM theophylline to the assay did not alter the levels of adenylate cyclase observed.
The product of the enzyme reaction in the assay was identified by thin-layer chromatography (see above) as [32P] found reduced levels in these cells (Fig. 1) . The responses to hormonial stimiiulationi aind NaF were likewise lower than normiial. These reductions were significaint at the level of P < 0.001, wheni the data were calculated either as the rate of cyclic ANIP synthesis per milligram protein or as the rate of synthesis per 106 cells (Fig. 1) . The extent of reductioin in adenylate cyclase activity did not correlate significaintly with the level of lymphocytosis (Fig. 2) . Treatmiieint stattus of the patient was also not a significanit variable.
Characterization ofabntormal response to hormones. The abnormal response of CLL lymvlphocyte adenylate cyclase to hormones or NaF might merely reflect the reduced basal enzyme activity, or it might be attributable to a specific reduced susceptibility of these cells to the normal stimulators of adenylate cyclase. Abnormalities in adenylate cyclase activities were analyzed in two ways: first differences between stimulated and basal levels were comiipared in the normal and patient populations; second, the ratios between stimulated and basal levels were examiiined (Table I) . Whereas the first method of comp-arison resulted in significant (P < 0.001) differences between normiials and patients, the ratios method of anialyzing the response to stimllulation did not distinguish normatl from CLL lymphocytes. Thus, the relative adeniylate cyclase activity is appropriately increased after exposure to hormones or NaF, whereas the absolute values attained remain abnorm-ial.
Analysis of T-aind B-lymtphocyte subpopulations. Because the CLL patienits assessed in these studies had lymphoproliferative (lisorders involving the B-cell line, it was imnportanit to comiipare their peripheral lymphocyte cyclic ANIP metabolism with normiial B cells, which comiiprise less thalni one-third of the circulatiing lymphocytes analyzed to normiial subjects. Therefore, adenylate cyclase was as sayecd in lymphocyte preparations enirichedl for T or B cells with standard purification proceduires (Table II) (Table II) . Likewise, normal, B-enriched lymphocytes differed significantly from CLL lymphocytes. The possibility was considered that artifactual differences between T and B cells could be generated as a result of the two purification techniques used. It should be noted that both nylon wool purification and E-rosetting fractionation resulted in data demonstrating that T enrichment lowered and T depletion (B enrichment) elevated adenylate cyclase activity (Table II) .
In three control experiments, enzyme activity was measured in B-enriched and T-enriched preparations obtained with a single fractionation method, the E-rosetting procedure. In this case, T cells were obtained by incubating Ficoll-Hypaque-purified E-rosetted lymphocytes at 37°C and vortexing for 30 s, followed by recentrifugation on a third Ficoll-Hypaque gradient. This recovery method avoids the perturbation of a lytic step, but produces an extremely poor yield of T cells. The results of three such experiments demonstrated elevation of adenylate cyclase with B enrichment and reduction of enzyme activity with T enrichment (Table  III) The above considerations strongly suggest that the T-and B-cell differences observed did not result from the purification methods used.
The data presented in Table II provide the possibility of setting up simultaneous equations to solve for the adenylate cyclase levels in pure B-and pure T-lymphocyte subpopulations. With this procedure, the calculated adenylate cyclase activities of normal T cells under basal conditions and after hormonal stimulation were <20% of the enzyme activities calculated for normal B cells (Table IV) . In contrast, CLL B cells had calculated adenylate cyclase levels similar to normal T cells, and far below those observed in normal B cells.
The calculated values of pure T-and B-lymphocyte The Ficoll-Hypaque-purified preparations contained 70±3% T cells and 22±3% B lymphocytes. The B-enriched subpopulation, derived from the interface of a second Ficoll-Hypaque gradient after E rosetting, contained 25±5% T cells and 63±7% B lymphocytes. The T-enriched subpopulation, derived from the E-rosetted pellet of the second Ficoll-Hypaque gradient, contained 88±2% T lymphocytes and 4±2% B cells. The numbers in parentheses refer to the number of experiments performed. Table I. adenylate cyclase activities were then reassessed to determine whether differences in the pattern of response to hormonal and NaF stimulation could now be detected. The ratios of stimulated to basal adenylate cyclase levels did not differ between normal lymphocytes, CLL B cells and CLL T lymphocytes (Table IV) . This further supports the conclusion that whereas the base-line activities vary in these lymphocyte subpopulations, the relative response to stimulation is not abnormal in CLL lymphocytes.
Comparison ofadenylate cyclase assays with normal and leukemic lymphocytes. Experiments were designed to rule out trivial explanations for observed differences between adenylate cyclase activities. Linearity of the assay over a 30-min incubation period and a linear relation between cell number and enzyme activity were established for the two lymphocyte populations under study (Fig. 3A and 3B) . The optimal Mg++ concentration was 4 mM in both cases (Fig. 3C) . The optimal concentrations of ISO and PGE1 in the adenylate cyclase assay were found to be 10-100 ,M in both cases.
To further compare the response of normal and CLL lymphocytes with hormones and chemical stimuli, two series of experiments were carried out assessing the effects of exposure to the /8-adrenergic antagonist, propranolol, and to Gpp(NH)p (24) (Table V) . As before, the method of ratios was used to compare adenylate cyclase activities in the presence and absence of these agents. In both normal and CLL lymphocytes, the elevation in adenylate cyclase activity resulting from incubation with ISO was completely prevented by simultaneous addition of propranolol, whereas the This factor is similar to the 6.4-fold reduction in basal enzyme activity observed in our study. It is of interest that the number of receptor sites for phytohemagglutinin is also diminished on the surface membranes of CLL lymphocytes (25) . Likewise, the number of smlg receptor sites is reduced (13) .
In the previous study of Polgar et al. (3) , the purification method for obtaining normal control lymphocytes was sedimentation, which results in enrichment of the study population for T cells (unpublished observations). Likewise, Sheppard et al. (4) enriched for T cells with their method of preparing normal lymphocytes for study because they used adherence to plastic and to nylon wool as purification methods. Our (7) . However, it should be noted that cyclic AMP phosphodiesterase activity is elevated in murine leukemia (26) and leukemic cell lines (27) .
The significance of the reduction in adenylate cyclase and cyclic AMP in CLL lymphocytes is conjectural. It is generally accepted that in human lymphocytes the proliferative responses to stimulation by antigens and mitogens is reduced as a result of exposure to added cyclic AMP (1, 2, 28) . In contrast, human lymphocytes stimulated to divide with phytohemagglutinin have reduced cyclic AMP levels (after a transient increase immediately after addition of the lectin) (22, 29 (32) .
Cyclic AMP levels have been assayed previously in studies of lymphocyte populations and subpopulations obtained from a number of murine and human lymphoid organs (33, 34) . Purified, human T cells had cyclic AMP levels of 1-2 pmol/106 cells, with higher values in peripheral blood cells than in thymocytes; purified B cells from tonsils and adenoids had levels of6 pmolIlO6 cells. Reduced cyclic AMP levels were also observed in human peripheral T cells by Atkinson et al. (35) . Thus, our observation of higher adenylate cyclase activity in circulating human B cells is quite consistent with the present and previous reports on cyclic AMP levels in human lymphocyte subpopulations.
The observations that adenylate cyclase activities, along with cyclic AMP levels, are lower in T cells than B cells in man raise some interesting questions for future study. At present, we have no evidence that circulating T cells are more actively cycling or functioning more than circulating B cells, but this is a testable hypothesis. In addition, it remains to be determined whether the differences between B and T lymphocytes persist after stimulation by antigens or mitogens.
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